News
Actemra Approved for Treatment of Hospitalized COVID-19 Patients
Actemra (tocilizumab) is an interleukin-6 receptor antagonist.
Your search for supplemental oxygen returned 4 results
News
FDA Authorizes Emergency Use of Kineret for Certain Hospitalized COVID-19 Patients
Kineret is an interleukin-1 receptor antagonist.
News
Olumiant Approved for COVID-19 Treatment in Hospitalized Adults
The approval was based on data from the phase 3 ACTT-2 and COV-BARRIER studies.
Drugs in the Pipeline
Tocilizumab Gets Priority Review for Treatment of Hospitalized COVID-19 Patients
The sBLA is supported by data from 4 randomized, controlled studies that evaluated tocilizumab for the treatment of COVID-19 in more than 5500 hospitalized patients.
